Bakary Conteh
YOU?
Author Swipe
View article: GETCampy Sequencing protocols v1
GETCampy Sequencing protocols v1 Open
As part of the GETCampy-Africa project, this protocol provides a modular workflow for extracting, sequencing, and analysing enteric pathogens from stool and environmental samples. It includes short-read (Illumina MiSeq) and long-read (Oxfo…
View article: Defining severe shigellosis in the Enterics for Global Health study: A comparison of leading diarrhea severity definitions among children with <i>Shigella</i> diarrhea
Defining severe shigellosis in the Enterics for Global Health study: A comparison of leading diarrhea severity definitions among children with <i>Shigella</i> diarrhea Open
Background Shigella has high global burden and serious long-term outcomes among young children. Increasing antibiotic resistance makes Shigella vaccine development a critical priority. Choosing the optimal clinical efficacy endpoint for Sh…
View article: Asymptomatic school children and adults are important for the human infectious reservoir for Plasmodium falciparum malaria in an area of low endemicity in The Gambia
Asymptomatic school children and adults are important for the human infectious reservoir for Plasmodium falciparum malaria in an area of low endemicity in The Gambia Open
In eastern Gambia, malaria transmission is maintained by asymptomatic malaria-infected individuals, mostly adults, adolescents and school-age children, while clinical cases are comparatively less important for transmission.
View article: The Consequences of&nbsp;Shigella&nbsp;Medically-Attended Diarrhea and Other Leading Pathogens Among Young Children Living in High-Burden Settings
The Consequences of Shigella Medically-Attended Diarrhea and Other Leading Pathogens Among Young Children Living in High-Burden Settings Open
View article: Incidence and Antimicrobial Resistance of&nbsp;Shigella-Attributable Diarrhea in Young Children: Results from the Multi-Country Enterics for Global Health (EFGH)&nbsp;Shigella&nbsp;Surveillance Study
Incidence and Antimicrobial Resistance of Shigella-Attributable Diarrhea in Young Children: Results from the Multi-Country Enterics for Global Health (EFGH) Shigella Surveillance Study Open
View article: Costs and Cost Drivers Of&nbsp;Shigella&nbsp;Medically Attended Diarrhoea: Results from the Enterics for Global Health (EFGH) Study
Costs and Cost Drivers Of Shigella Medically Attended Diarrhoea: Results from the Enterics for Global Health (EFGH) Study Open
View article: GetCampy_Laboratory Procedures v1
GetCampy_Laboratory Procedures v1 Open
This standard operating procedure (SOP) outlines the preparation, quality control, and application of Motility-Indole-Urease (MIU) agar and Triple Sugar Iron (TSI) agar slants for the biochemical identification of Gram-negative enteric pat…
View article: Household-level effects of seasonal malaria chemoprevention in the Gambia
Household-level effects of seasonal malaria chemoprevention in the Gambia Open
Background In 2022 the WHO recommended the discretionary expansion of the eligible age range for seasonal malaria chemoprevention (SMC) to children older than 4 years. Older children are at lower risk of clinical disease and severe malaria…
View article: Histoplasma seropositivity and environmental risk factors for exposure in a general population in Upper River Region, The Gambia: A cross-sectional study
Histoplasma seropositivity and environmental risk factors for exposure in a general population in Upper River Region, The Gambia: A cross-sectional study Open
Robust surveillance of Histoplasma species is warranted in endemic regions, including investigation of community-level transmission dynamics. This cross-sectional study explored anti-Histoplasma antibody seroprevalence and ri…
View article: The Enterics for Global Health (EFGH) <i>Shigella</i> Surveillance Study in The Gambia
The Enterics for Global Health (EFGH) <i>Shigella</i> Surveillance Study in The Gambia Open
Background The Gambia, located in West Africa, is one of 7 country sites conducting the Enterics for Global Health (EFGH) Shigella Surveillance Study to establish incidence and consequence of Shigella-associated medically attended diarrhea…
View article: Population Enumeration and Household Utilization Survey Methods in the Enterics for Global Health (EFGH): <i>Shigella</i> Surveillance Study
Population Enumeration and Household Utilization Survey Methods in the Enterics for Global Health (EFGH): <i>Shigella</i> Surveillance Study Open
Background Accurate estimation of diarrhea incidence from facility-based surveillance requires estimating the population at risk and accounting for case patients who do not seek care. The Enterics for Global Health (EFGH) Shigella surveill…
View article: Data Management in Multicountry Consortium Studies: The Enterics For Global Health (EFGH) <i>Shigella</i> Surveillance Study Example
Data Management in Multicountry Consortium Studies: The Enterics For Global Health (EFGH) <i>Shigella</i> Surveillance Study Example Open
Background Rigorous data management systems and planning are essential to successful research projects, especially for large, multicountry consortium studies involving partnerships across multiple institutions. Here we describe the develop…
View article: Quantifying the Cost of <i>Shigella</i> Diarrhea in the Enterics for Global Health (EFGH) <i>Shigella</i> Surveillance Study
Quantifying the Cost of <i>Shigella</i> Diarrhea in the Enterics for Global Health (EFGH) <i>Shigella</i> Surveillance Study Open
Background Comparative costs of public health interventions provide valuable data for decision making. However, the availability of comprehensive and context-specific costs is often limited. The Enterics for Global Health (EFGH) Shigella s…
View article: Diarrhea Case Surveillance in the Enterics for Global Health <i>Shigella</i> Surveillance Study: Epidemiologic Methods
Diarrhea Case Surveillance in the Enterics for Global Health <i>Shigella</i> Surveillance Study: Epidemiologic Methods Open
Background Shigella is a leading cause of acute watery diarrhea, dysentery, and diarrhea-attributed linear growth faltering, a precursor to stunting and lifelong morbidity. Several promising Shigella vaccines are in development and field e…
View article: Household-level effects of seasonal malaria chemoprevention in the Gambia
Household-level effects of seasonal malaria chemoprevention in the Gambia Open
In 2022 the WHO recommended the discretionary expansion of the eligible age range for seasonal malaria chemoprevention to children older than 4 years. Older children are at lower risk of clinical disease and severe malaria so there has bee…
View article: Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial
Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial Open
View article: Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial
Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial Open
Background Pyronaridine-artesunate (PA) is a registered artemisinin-based combination therapy, potentially useful for mass drug administration campaigns. However, further data are needed to evaluate its efficacy, safety and tolerability as…
View article: From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia
From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia Open
Background The World Health Organization (WHO) recommends consideration of mass drug administration (MDA) for malaria control in low-endemic settings approaching elimination. However, MDA remains a controversial strategy, as multiple indiv…
View article: Additional file 1 of From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia
Additional file 1 of From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia Open
Additional file 1: Table S1. Demographic, social, and implementation factors associated with consent and enrollment, coverage, and adherence in the MDA trial based on surveyed respondents.
View article: From Informed Consent to Adherence: Factors Influencing Involvement in Mass Drug Administration With Ivermectin for Malaria Elimination in The Gambia
From Informed Consent to Adherence: Factors Influencing Involvement in Mass Drug Administration With Ivermectin for Malaria Elimination in The Gambia Open
Background : The World Health Organization (WHO) recommends consideration of mass drug administration (MDA) for malaria control in low-endemic settings approaching elimination. However, MDA remains a controversial strategy, as multiple ind…
View article: Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial
Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial Open
Background With a decline in malaria burden, innovative interventions and tools are required to reduce malaria transmission further. Mass drug administration (MDA) of artemisinin-based combination therapy (ACT) has been identified as a pot…
View article: Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial (Preprint)
Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial (Preprint) Open
BACKGROUND With a decline in malaria burden, innovative interventions and tools are required to reduce malaria transmission further. Mass drug administration (MDA) of artemisinin-based combination therapy (ACT) has been identified as a po…